Robotic-Assisted Radical Prostatectomy
The surgical removal of the prostate for prostate cancer — performed with nerve-sparing robotic technique, pre-operative pelvic floor preparation, and a structured survivorship programme from day one.
stay
(all patients)
(nerve-sparing)
safety pad by day
activity
What is a robotic radical prostatectomy?
Robotic-assisted radical prostatectomy (RARP) is the surgical removal of the entire prostate gland and seminal vesicles for clinically localised or locally advanced prostate cancer. Robotic surgery is now the dominant technique — offering greater precision than open or conventional laparoscopic approaches, with particular advantages for nerve preservation and accurate reconstruction of the bladder-urethra join.
The procedure is performed using the da Vinci system through six small keyhole incisions. The surgeon operates at a console with three-dimensional magnified vision and wristed instruments delivering precision beyond the unassisted hand. The prostate is dissected from surrounding structures, the bladder neck is rejoined to the urethra, and a catheter remains in place for approximately one week while the anastomosis heals.
The principal goals are complete cancer removal with negative surgical margins, while preserving the structures responsible for urinary continence and — where oncologically safe — erectile function. For localised prostate cancer, robotic surgery and radiotherapy offer equivalent cancer control; the choice between them is personal, and discussed openly at consultation. NICE guidance (NG131) sets out the current UK recommended pathway.
What to expect with urinary control
Temporary urinary leakage following catheter removal is expected and normal. The rate and completeness of recovery depend on age, baseline function, and surgical technique. The key target to aim for at 6 weeks is to be dry at night and using a single safety pad during the day. Meeting this milestone places you ahead of the curve in terms of continence recovery.
Pelvic floor exercises — starting before surgery and restarting the moment the catheter is removed — are the single most impactful thing a patient can do to influence their recovery.
Timeline
Pelvic floor preparation — start before your operation
Pre-operative pelvic floor training is one of the most evidence-based and impactful things a patient can do before prostatectomy. Patients who begin exercises before surgery recover continence significantly faster than those who start only after the catheter comes out. By training the pelvic floor beforehand, you develop the neuromuscular control you will depend on the moment the catheter is removed.
Mr Sri refers all prostatectomy patients for specialist pelvic floor physiotherapy before their operation. Exercises should begin at least four to six weeks before the planned surgery date.
Patient resources from Prostate Cancer UK — the UK's leading prostate cancer charity:
Survivorship — the long view
The goal of treatment is not just cancer control — it is getting back to living well. Mr Sri's approach places equal emphasis on excellent oncological outcomes and quality of life in the years following surgery.
The operation — step by step
Frequently asked questions
Full information on the prostate cancer page.
In most cases there is time to consider your options fully — a few weeks to understand the alternatives and seek a second opinion will not compromise your outcome. Mr Sri will advise clearly if there is any clinical reason to act with greater urgency. Rushing a decision of this magnitude is never recommended when it can be avoided.
No. The majority of patients achieve social continence within the first year. At 6 weeks, the realistic expectation is dry at night and a single pad during the day for security. Pelvic floor exercises before and after surgery are the most important factor influencing recovery speed. Persistent leakage beyond 12 months is assessed for further interventions.
A PSA rise after prostatectomy — biochemical recurrence — does not necessarily mean the cancer has spread. Management depends on the timing, rate of rise, and pathological features. Options include active surveillance, salvage radiotherapy to the prostate bed, and systemic treatment. All decisions are made through the MDT with full patient involvement.
Both offer equivalent cancer control in most risk categories. Surgery's primary risks relate to urinary continence and erectile function; radiotherapy's primary risks relate to bowel and bladder irritation and long term erectile dysfunction. The right choice depends on your cancer characteristics, general health, and personal priorities. Mr Sri discusses both openly and refers directly to clinical oncology colleagues where radiotherapy is preferred. NICE NG131 sets out the current decision framework.
Further information
Clinic locations
Tel: 020 8337 6691
Tel: 020 8971 8000
Tel: 020 379 77248
Ready to discuss your prostate cancer treatment?
Same-week appointments available. No GP referral required. All major insurers and self-pay.